See also our related blog for the Pediatric Preclinical Testing Initiative.

Tuesday, February 15, 2011

Welcoming Lara !

We are excited to welcome physician-scientist trainee, Dr. Lara Davis to the Keller laboratory.  Lara is one of those rare physicians who will be qualified to treat both child and adult cancer patients.

in Lara's words:

After graduating from Wellesley College with a BA in Neuroscience, I attended medical school at OHSU where learning about new targeted therapies such as Gleevec sparked my interest in oncology early on.  During medical school, I found myself enjoying caring for both children and adults with cancer and thus decided to pursue residency training in Med-Peds.  I completed the four-year training in the Harvard Med-Peds Program at Brigham & Women’s Hospital and Children’s Hospital Boston and am now board certified in both Internal Medicine and Pediatrics.  My interest in oncology evolved throughout residency to a focus on adolescents and young adults (AYA), an often over-looked population.  I worked with Dr Linda Stork and Dr Brandon Hayes-Lattin to design a combined fellowship at OHSU and am now completing my second clinical year (one in peds hem/onc, one in medical onc).  This summer I will join the Keller lab to pursue my interest in identifying targeted therapies for cancers that disproportionately affect AYA patients, particularly sarcomas.
We are thankful to have such a talented young person join our team.  We fully expect that Lara will be a future leader in personalized medicine for sarcomas, particularly osteosarcoma.